非透析依赖慢性肾脏病患者的骨折及其后遗症:斯德哥尔摩肌酐测量项目
CKD分期越重骨折风险越高,骨折后90天内死亡和MACE风险显著增加,提示需加强骨折后监测与预防。
要点
- CKD 3b、4、5期较3a期骨折风险递增,5期髋部骨折风险显著升高。
- 骨折后90天内死亡风险约为无骨折期的4倍,髋部骨折后风险更高。
- 骨折后90天内MACE风险亦显著升高,且风险持续超过90天。
核心结论
- CKD患者骨折常见,且骨折后死亡和MACE风险显著增加,尤其髋部骨折后。
- 结果可用于指导骨折后临床监测和骨折预防策略。
研究设计与样本
- 纳入68 764例确诊CKD 3-5期且无骨折史的成人,平均年龄79岁,56%女性。
- 以eGFR为时间依赖暴露分析骨折发生率,以骨折为时间变化暴露用Cox回归分析死亡和MACE风险。
主要发现
- 中位随访2.7年,共发生9219例骨折,其中3105例为髋部骨折。
- 与CKD 3a期相比,3b、4、5期调整后骨折HR分别为1.10(95%CI 1.02-1.19)、1.32(95%CI 1.17-1.49)、2.47(95%CI 1.94-3.15)。
- eGFR<30 mL/min/1.73 m2时,骨折风险呈线性关联。
- 骨折后90天内死亡HR为4.21(95%CI 3.95-4.49),90天后HR为1.47(95%CI 1.40-1.54)。
- 骨折后90天内MACE HR为4.02(95%CI 3.73-4.33),90天后HR为1.20(95%CI 1.10-1.30)。
临床怎么用
- 对CKD 3-5期患者应评估骨折风险,尤其CKD 4-5期及eGFR<30 mL/min/1.73 m2者。
- 骨折后90天内需加强死亡和心血管事件监测,髋部骨折后风险更高。
- 考虑将骨折预防策略纳入CKD管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: People undergoing maintenance dialysis are at high risk for fractures, but less is known about fracture incidence and associated outcomes in earlier stages of chronic kidney disease (CKD). METHODS: We conducted an observational analysis from the Stockholm Creatinine Measurement project, a Swedish health care utilization cohort during 2006-11. We identified all adults with confirmed CKD Stages 3-5 and no documented history of fractures and extracted information on comorbid history, ongoing medication, cardiovascular events and death. We studied incidence rates of fractures (overall and by location), with the estimated glomerular filtration rate (eGFR) as time-dependent exposure. We then studied hazard ratios [HRs and 95% confidence intervals (CIs)] for the events of death and major adverse cardiac events (MACE) using Cox regression with fracture as time-varying exposure. RESULTS: We identified 68 764 individuals with confirmed CKD (mean age 79 years, 56% women). During a median follow-up of 2.7 years, 9219 fractures occurred, of which 3105 were hip fractures. A more severe CKD stage was associated with a higher risk of fractures, particularly hip fractures: compared with CKD Stage 3a, the adjusted HR was 1.10 (95% CI 1.02-1.19), 1.32 (1.17-1.49) and 2.47 (1.94-3.15) for CKD Stage 3b, 4 and 5, respectively. Spline curves suggested a linear association with fracture risk with an eGFR <30 mL/min/1.73 m2. Compared with non-fracture periods, incident fracture was associated with a 4-fold increased mortality within 90 days [HR 4.21 (95% CI 3.95-4.49)]. The risk remained elevated beyond 90 days [HR 1.47 (95% CI 1.40-1.54)] and was stronger after hip fractures. Post-fracture MACE risk was also highest in the first 90 days [HR 4.02 (95% CI 3.73-4.33)], particularly after hip fractures, and persisted beyond 90 days [HR 1.20 (95% CI 1.10-1.30)]. CONCLUSION: Our findings highlight the commonness of fractures and the increased risk for subsequent adverse outcomes in CKD patients. These results may inform clinical decisions regarding post-fracture clinical surveillance and fracture prevention strategies.
引用
- Runesson B, Trevisan M, Iseri K, et al. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project. Nephrol Dial Transplant. 2020. PMID: 31361316. doi:10.1093/ndt/gfz142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。